COX-2/5-LOX Dual Acting Anti-Inflammatory Drugs in Cancer Chemotherapy

E-ISSN： 1873-4294|7|3|283-296

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.7, Iss.3, 2007-02, pp. : 283-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual Acting Anti-Inflammatory Drugs

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 3, 2007-02 ,pp. : 265-275

Bentham Science Publishers

Access to resources Recommend Favorite

Dual acting anti-inflammatory drugs: a reappraisal

By Bertolini A. Ottani A. Sandrini M.

Pharmacological Research, Vol. 44, Iss. 6, 2001-12 ,pp. : 437-450

Academic Press

Access to resources Recommend Favorite

Selective COX-2 Inhibitors and Dual Acting Anti-inflammatory Drugs: Critical Remarks

Current Medicinal Chemistry, Vol. 9, Iss. 10, 2002-05 ,pp. : 1033-1043

Bentham Science Publishers

Access to resources Recommend Favorite

Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs

By Charlier C. Michaux C.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 645-659

Elsevier

Access to resources Recommend Favorite

Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer

Current Medicinal Chemistry, Vol. 22, Iss. 24, 2015-01 ,pp. : 2812-2818

Bentham Science Publishers

Access to resources Recommend Favorite